|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 403/14 | (2006.01) |
| C07D 403/14 | (2013.01) | ||
| C07D 401/14 | (2006.01) | ||
| C07D 401/14 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61K 31/4709 | (2006.01) |
| (11) | Number of the document | 3795570 |
| (13) | Kind of document | T |
| (96) | European patent application number | 20177662.2 |
| Date of filing the European patent application | 2020-06-01 | |
| (97) | Date of publication of the European application | 2021-03-24 |
| (45) | Date of publication and mention of the grant of the patent | 2022-02-23 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201962904007 P | 2019-09-23 | US |
| (72) |
FAN, Jie , US
QIAN, Yimin , US
HE, Wei , US
LIU, Ke , US
|
| (73) |
Accutar Biotechnology Inc. ,
760 Parkside Avenue
Room 213, Brooklyn, NY 11226,
US
|
| (54) | SUBSTITUTED QUINOLINE-8-CARBONITRILE DERIVATIVES HAVING ANDROGEN RECEPTOR DEGRADATION ACTIVITY AND USES THEREOF |
| SUBSTITUTED QUINOLINE-8-CARBONITRILE DERIVATIVES HAVING ANDROGEN RECEPTOR DEGRADATION ACTIVITY AND USES THEREOF |